Boston – September 16, 2026 -- PerZeption Inc. has secured a Phase I Small Business Innovation Research (SBIR) grant from the National Eye Institute to fund development of a new photostress recovery test for age-related macular degeneration (AMD), a condition affecting an estimated 20 million people in the United States.